 |
|||||
 |
|||||
|
|||||
 |
|||||
 |
|||||
|
|||||
 |
|||||
 |
Dr. Paul Janssen (1926-2003) was one of the 20th century's most innovative and inspiring pharmaceutical researchers. His work was responsible for many breakthroughs in several fields of disease, including pain management, psychiatry, infectious disease and gastroenterology. Furthermore, he has more than 100 patents to his name.
Dr. Paul, as he was known throughout the global scientific community, was an exceptionally gifted and passionate scientist who revolutionized modern medicine and inspired a new generation of researchers. In 1953, Dr. Paul established Janssen Pharmaceutica, N.V., a pharmaceutical research laboratory based in Beerse, Belgium. In Beerse, he laid the foundation for more than 80 medicines that have saved millions of lives.
One such medicine, HALDOL® (haloperidol), was the first antipsychotic therapy that allowed patients to be treated at home. Prior to HALDOL, the only treatments for psychosis were associated with crippling side effects. Even today, HALDOL continues to be used for the management of psychosis. Dr. Paul was also working at the development of FENTANYL®, the most widely used anesthetic worldwide, and REASEC®, (diphenoxylate), used for the treatment of diarrhea, which had been a disabling and sometimes fatal disease in developing countries.
Janssen Pharmaceutica, N.V., became part of the Johnson & Johnson Family of Companies in 1961. Throughout Dr. Paul's lifetime, he received many awards, including five honorary professorships and 22 honorary doctorates. He was author or co-author of more than 850 scientific publications and was honorary member of over 30 scientific institutes and organizations.
Nobel Prize Winner Sir James W. Black Remembers Dr. Paul Janssen
 |
